Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-058-5 | CAS number: 298-12-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In a reverse gene mutation assay in bacteria strains TA 1535, TA 1537, TA 1538, TA 98 and TA 100 of S. typhimurium and WP2 uvrA of E. Coli were exposed to Glyoxylic Acid at concentrations of 0, 4, 20, 100, 500, 2500, 5000 or 10000 µg/plate (3 plates/dose) in the presence and absence of mammalian metabolic activation applying the standard plate method. Cytotoxicity was observed at 2500 µg/plate and higher doses. The positive controls induced the appropriate responses in the corresponding strains. There was no evidence of induced mutant colonies over background.
This study is classified as acceptable and satisfies the requirement for test guideline OECD 471 for in vitro mutagenicity (bacterial reverse gene mutation) data.
An in vitro mammalian cell mutagenicity study was performed to investigate the potential of Glyoxylic Acid 50 % to induce mutations at the mouse lymphoma thymidine kinase locus using the cell line L5178Y. The treatment period was 4 h in the first experiment with and without metabolic activation. In the second experiment, the treatment period was 24 h without metabolic activation and 4 h in the presence of metabolic activation.
The highest applied concentration in the pre-test on toxicity (750 µg/mL about 10 mM) was chosen with regard to the current OECD Guideline 476.
No substantial and reproducible dose dependent increase in mutant colony numbers was observed in both main experiments. No relevant and reproducible shift of the ratio of small versus large colonies was observed up to the maximal concentration of the test item. A moderate increase of the mutation frequency observed in the first experiment at 112.5 µg/mL was not reproduced in the second experiment and therefore, judged as biologically irrelevant. Appropriate reference mutagens were used as positive controls and showed a distinct increase in induced mutant colonies, indicating that the tests were sensitive and valid.
In a Crl:Cobs CD-1 mouse bone marrow micronucleus assay, 4 animals/sex/dose were treated by gavage with Glyoxylic Acid 50% at doses of 0, 183, 366, or 914 mg/kg bw. The vehicle was water. The highest dose corresponded to 1/2 of the mouse LD50 and thus represents the maximum tolerable dose. Bone marrow cells were harvested 24 hours post-treatment. There were no signs of toxicity during the study. The positive controls (Benzo(a)pyrene and Cyclophosphamide) induced the appropriate response. There was not a significant increase in the frequency of micronucleated polychromatic erythrocytes in bone marrow up to the dose of 914 mg/kg bw after treatment time.
Short description of key information:
No potential for genetic toxicity of Glyoxylic Acid 50% was indicated in the Ames Test, the Mouse Lymphoma Test and the Bone Marrow Micronucleus Test.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Based on the negative in vitro results supported by negative in vivo testing, Glyoxylic Acid 50% has not to be classified and labelled mutagenic according to EU Regulation No. 1272/2008 and EU Directive 67/548/EEC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.